352 related articles for article (PubMed ID: 16455766)
61. Dystrophin involved in the susceptibility of slow muscles to hindlimb unloading via concomitant activation of TGF-β1/Smad3 signaling and ubiquitin-proteasome degradation in mice.
Zhang P; Li W; Liu H; Li J; Wang J; Li Y; Chen X; Yang Z; Fan M
Cell Biochem Biophys; 2014 Nov; 70(2):1057-67. PubMed ID: 24839113
[TBL] [Abstract][Full Text] [Related]
62. Atrogin-1/MAFbx and MuRF1 are downregulated in aging-related loss of skeletal muscle.
Edström E; Altun M; Hägglund M; Ulfhake B
J Gerontol A Biol Sci Med Sci; 2006 Jul; 61(7):663-74. PubMed ID: 16870627
[TBL] [Abstract][Full Text] [Related]
63. Iron-induced skeletal muscle atrophy involves an Akt-forkhead box O3-E3 ubiquitin ligase-dependent pathway.
Ikeda Y; Imao M; Satoh A; Watanabe H; Hamano H; Horinouchi Y; Izawa-Ishizawa Y; Kihira Y; Miyamoto L; Ishizawa K; Tsuchiya K; Tamaki T
J Trace Elem Med Biol; 2016 May; 35():66-76. PubMed ID: 27049128
[TBL] [Abstract][Full Text] [Related]
64. Myostatin induces degradation of sarcomeric proteins through a Smad3 signaling mechanism during skeletal muscle wasting.
Lokireddy S; McFarlane C; Ge X; Zhang H; Sze SK; Sharma M; Kambadur R
Mol Endocrinol; 2011 Nov; 25(11):1936-49. PubMed ID: 21964591
[TBL] [Abstract][Full Text] [Related]
65. The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors.
Stitt TN; Drujan D; Clarke BA; Panaro F; Timofeyva Y; Kline WO; Gonzalez M; Yancopoulos GD; Glass DJ
Mol Cell; 2004 May; 14(3):395-403. PubMed ID: 15125842
[TBL] [Abstract][Full Text] [Related]
66. Ubiquitin-protein ligases in muscle wasting.
Cao PR; Kim HJ; Lecker SH
Int J Biochem Cell Biol; 2005 Oct; 37(10):2088-97. PubMed ID: 16125112
[TBL] [Abstract][Full Text] [Related]
67. A cell-autonomous role for the glucocorticoid receptor in skeletal muscle atrophy induced by systemic glucocorticoid exposure.
Watson ML; Baehr LM; Reichardt HM; Tuckermann JP; Bodine SC; Furlow JD
Am J Physiol Endocrinol Metab; 2012 May; 302(10):E1210-20. PubMed ID: 22354783
[TBL] [Abstract][Full Text] [Related]
68. Glycogen synthase kinase-3β is required for the induction of skeletal muscle atrophy.
Verhees KJ; Schols AM; Kelders MC; Op den Kamp CM; van der Velden JL; Langen RC
Am J Physiol Cell Physiol; 2011 Nov; 301(5):C995-C1007. PubMed ID: 21832246
[TBL] [Abstract][Full Text] [Related]
69. Involvement of the FoxO1/MuRF1/Atrogin-1 Signaling Pathway in the Oxidative Stress-Induced Atrophy of Cultured Chronic Obstructive Pulmonary Disease Myotubes.
Pomiès P; Blaquière M; Maury J; Mercier J; Gouzi F; Hayot M
PLoS One; 2016; 11(8):e0160092. PubMed ID: 27526027
[TBL] [Abstract][Full Text] [Related]
70. Smad7 gene delivery prevents muscle wasting associated with cancer cachexia in mice.
Winbanks CE; Murphy KT; Bernardo BC; Qian H; Liu Y; Sepulveda PV; Beyer C; Hagg A; Thomson RE; Chen JL; Walton KL; Loveland KL; McMullen JR; Rodgers BD; Harrison CA; Lynch GS; Gregorevic P
Sci Transl Med; 2016 Jul; 8(348):348ra98. PubMed ID: 27440729
[TBL] [Abstract][Full Text] [Related]
71. Ghrelin receptor agonist, GHRP-2, attenuates burn injury-induced MuRF-1 and MAFbx expression and muscle proteolysis in rats.
Sheriff S; Joshi R; Friend LA; James JH; Balasubramaniam A
Peptides; 2009 Oct; 30(10):1909-13. PubMed ID: 19577604
[TBL] [Abstract][Full Text] [Related]
72. Testosterone protects against dexamethasone-induced muscle atrophy, protein degradation and MAFbx upregulation.
Zhao W; Pan J; Zhao Z; Wu Y; Bauman WA; Cardozo CP
J Steroid Biochem Mol Biol; 2008 May; 110(1-2):125-9. PubMed ID: 18436443
[TBL] [Abstract][Full Text] [Related]
73. Inhibition of the ubiquitin-proteasome pathway does not protect against ventilator-induced accelerated proteolysis or atrophy in the diaphragm.
Smuder AJ; Nelson WB; Hudson MB; Kavazis AN; Powers SK
Anesthesiology; 2014 Jul; 121(1):115-26. PubMed ID: 24681580
[TBL] [Abstract][Full Text] [Related]
74. Preventive Effects of Schisandrin A, A Bioactive Component of
Yeon M; Choi H; Jun HS
Nutrients; 2020 Apr; 12(5):. PubMed ID: 32354126
[TBL] [Abstract][Full Text] [Related]
75. Hydrogen sulphide ameliorating skeletal muscle atrophy in db/db mice via Muscle RING finger 1 S-sulfhydration.
Lu F; Lu B; Zhang L; Wen J; Wang M; Zhang S; Li Q; Shu F; Sun Y; Liu N; Peng S; Zhao Y; Dong S; Zhao D; Lu F; Zhang W
J Cell Mol Med; 2020 Aug; 24(16):9362-9377. PubMed ID: 32633463
[TBL] [Abstract][Full Text] [Related]
76. Ubiquitin-protein ligases in muscle wasting: multiple parallel pathways?
Lecker SH
Curr Opin Clin Nutr Metab Care; 2003 May; 6(3):271-5. PubMed ID: 12690258
[TBL] [Abstract][Full Text] [Related]
77. Targeting the ubiquitin E3 ligase MuRF1 to inhibit muscle atrophy.
Eddins MJ; Marblestone JG; Suresh Kumar KG; Leach CA; Sterner DE; Mattern MR; Nicholson B
Cell Biochem Biophys; 2011 Jun; 60(1-2):113-8. PubMed ID: 21448668
[TBL] [Abstract][Full Text] [Related]
78. Sepsis-induced increase in muscle proteolysis is blocked by specific proteasome inhibitors.
Hobler SC; Tiao G; Fischer JE; Monaco J; Hasselgren PO
Am J Physiol; 1998 Jan; 274(1):R30-7. PubMed ID: 9458895
[TBL] [Abstract][Full Text] [Related]
79. Heart failure increases atrogin-1 and MuRF1 gene expression in skeletal muscle with fiber type-specific atrophy.
Carvalho RF; Castan EP; Coelho CA; Lopes FS; Almeida FL; Michelin A; de Souza RW; Araújo JP; Cicogna AC; Dal Pai-Silva M
J Mol Histol; 2010 Feb; 41(1):81-7. PubMed ID: 20349269
[TBL] [Abstract][Full Text] [Related]
80. Treatment with pharmacological PPARα agonists stimulates the ubiquitin proteasome pathway and myofibrillar protein breakdown in skeletal muscle of rodents.
Ringseis R; Keller J; Lukas I; Spielmann J; Most E; Couturier A; König B; Hirche F; Stangl GI; Wen G; Eder K
Biochim Biophys Acta; 2013 Jan; 1830(1):2105-17. PubMed ID: 23041501
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
